Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Regarding their glycaemic effectiveness (how much a drug lowers blood sugar, measured as the HbA1c level after 12 months), after first-line metformin GLP-1R agonists ranked optimal for 33% of initiations overall (71% in females, 9% in males); SGLT2 inhibitors for 29%; sulfonylureas for 28%; thiazolidinediones for 10%; [DPP-4 inhibitors](brain://c9xymjapY06RYrAWIRkAFw/Cd26Dipeptid…